Allogene Therapeutics, Inc.
ALLO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737287
In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Allogene Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 170 | 7 | 172 | +9 |
| Shares | 162.1M | 2.44M | 162.7M | +2.99M (+1.9%) |
| Value | $201.0M | $3.02M | $222.7M | +$24.7M (+12.5%) |
7 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (29)
Institutions that held Allogene Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (20)
Institutions that held Allogene Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Lynx1 Capital Management LP | 546,119 | $677.2K |
| Macquarie Group Ltd | 146,779 | $182.0K |
| Atom Investors LP | 85,930 | $106.6K |
| Dynamic Technology Lab Private Ltd | 39,677 | $50.0K |
| SRS Capital Advisors, Inc. | 37,401 | $46.4K |
| Engineers Gate Manager LP | 36,446 | $45.2K |
| Scientech Research LLC | 26,635 | $33.0K |
| Brighton Jones LLC | 25,168 | $31.2K |
| Envestnet Asset Management Inc | 18,602 | $23.1K |
| Prudential Financial Inc | 15,930 | $19.8K |
| Seven Mile Advisory | 14,434 | $17.9K |
| Principal Financial Group Inc | 11,993 | $14.9K |
| HighTower Advisors, LLC | 11,740 | $14.6K |
| Oppenheimer & Co Inc | 10,500 | $13.0K |
| Axxcess Wealth Management, LLC | 10,208 | $12.7K |
| DLK Investment Management, LLC | 10,000 | $12.4K |
| Advisory Services Network, LLC | 4,069 | $5.05K |
| Clearstead Advisors, LLC | 837 | $1.04K |
| Rise Advisors, LLC | 827 | $1.02K |
| Hoey Investments, Inc | 300 | $372 |
Not filed for Q4 2025 yet (7)
Institutions that held Allogene Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $2.23M |
| Moloney Securities Asset Management, LLC | 514,000 | $637.4K |
| Cubist Systematic Strategies, LLC | 102,771 | $127.4K |
| CIBC Bancorp USA Inc. | 16,163 | $20.0K |
| Point72 (DIFC) Ltd | 6,215 | $7.71K |
| Point72 Europe (London) LLP | 1,077 | $1.33K |
| West Oak Capital, LLC | 100 | $100 |